CDE Launches Technical Guidelines to Emphasize Patient-Centered Drug Clinical Trials
The Center for Drug Evaluation (CDE) has released a series of Technical Guidelines that encompass...
Policy / Regulatory
Pingshan District and Fosun Pharma Ink Strategic Deal to Boost Biomedical Industry
The People’s Government of Pingshan District in Shenzhen has signed a cooperation framework agreement with...
EU Commits EUR 3 Million to Strengthen Healthcare Access in Latin America and Caribbean
The European Union (EU) has announced a EUR 3 million (USD 3.3 million) funding injection...
Taiwan’s TFDA Orders Recall of Two Nucala Batches Due to Glass Fragments
The Food and Drug Administration (FDA) bureau of Taiwan, part of Greater China, has issued...
NMPA Updates List of Medical Devices Exempt from Clinical Evaluation in China
The National Medical Products Administration (NMPA) has released an updated version of the “List of...
Chinese Health Authorities Unveil Key Reform Tasks for Medical System in H2 2023
The National Health Commission (NHC), National Development and Reform Commission (NDRC), Ministry of Finance (MoF),...
NHSA Releases Official Guidelines for Drug Negotiations and Bidding for NRDL Update
The National Healthcare Security Administration (NHSA) has officially released the “Negotiation Drug Renewals” and “Non-exclusive...
National Health Commission Launches One-Year Anti-Corruption Campaign in Pharmaceutical Sector
The emergency response department of the National Health Commission (NHC) has released a notification signaling...
Johnson & Johnson Files Lawsuit Against US Government’s Drug Pricing Negotiation Authority
United States-based Johnson & Johnson (J&J, NYSE: JNJ) has filed a lawsuit this week, challenging...
US Merger Guidelines Updated: Public Comment Sought on Antitrust Law Changes
The United States has published an update to its merger and acquisition guidelines, seeking public...
NMPA Releases 70th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 70th batch of reference drugs for...
China’s NHC Issues Guidelines to Enhance Clinical Department Capacities for Serious Diseases
The National Health Commission (NHC) has issued a set of guidelines aimed at strengthening clinical...
NHSA Unveils 2023 Flying Inspection Plan for Medical Insurance Fund Oversigh
The National Healthcare Security Administration (NHSA) has released its 2023 Basic Medical Insurance (BMI) Fund...
Chile Expands Financial Coverage for AbbVie’s RSV Prophylaxis Synagis
Chile’s Ministry of Health (MINSAL) has announced an immediate expansion in the coverage under its...
US FDA Approves Additional Shipments of Qilu Pharmaceutical’s Cisplatin to Address Shortage
The US Food and Drug Administration (FDA) is maintaining its reliance on China-based Qilu Pharmaceutical...
NHSA’s 2022 Report: BMI Fund Income Rises 7.6%, Outgoing Expenditure Increases 2.3%
The National Healthcare Security Administration (NHSA) has released its annual statistical report for 2022, detailing...
Shanghai’s SMPA Initiates Volume-Based Procurement for National VBP Drugs in Alliance Region
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has released a notification indicating the commencement of follow-up...
China’s NAFR Enhances Tax Benefits for Private Health Insurance Purchases
The National Administration of Financial Regulation (NAFR) in China has issued a Notification indicating that...
CDE Launches Trial Procedures for Adding Pediatric Information to Drug Inserts
The Center for Drug Evaluation (CDE) has released the “Work Procedures for Adding Children’s Drug...
NMPA Launches “Drug Standard Management Measures” to Enhance Drug Quality and Safety
The National Medical Products Administration (NMPA) has released the “Drug Standard Management Measures,” a set...